Ardent Health, Inc. (NYSE:ARDT – Get Free Report) has been assigned an average rating of “Hold” from the twelve ratings firms that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $15.00.
Several brokerages have recently issued reports on ARDT. Stephens reduced their price target on shares of Ardent Health from $21.00 to $17.00 and set an “overweight” rating on the stock in a research report on Friday, November 14th. Royal Bank Of Canada cut their target price on shares of Ardent Health from $21.00 to $16.00 and set an “outperform” rating on the stock in a research note on Friday, November 14th. Bank of America decreased their price target on shares of Ardent Health from $12.00 to $10.00 and set an “underperform” rating for the company in a research report on Thursday, November 13th. UBS Group assumed coverage on Ardent Health in a research report on Wednesday, September 10th. They set a “buy” rating and a $17.00 price objective on the stock. Finally, JPMorgan Chase & Co. reduced their price objective on Ardent Health from $15.00 to $12.00 and set a “neutral” rating on the stock in a research note on Monday, November 24th.
Get Our Latest Report on Ardent Health
Hedge Funds Weigh In On Ardent Health
Ardent Health Trading Down 3.0%
ARDT opened at $8.78 on Friday. Ardent Health has a 52 week low of $8.28 and a 52 week high of $17.34. The company has a quick ratio of 1.95, a current ratio of 2.08 and a debt-to-equity ratio of 0.67. The business has a fifty day simple moving average of $12.95 and a 200-day simple moving average of $13.00. The firm has a market cap of $1.26 billion, a P/E ratio of 6.06, a P/E/G ratio of 7.23 and a beta of 0.44.
Ardent Health (NYSE:ARDT – Get Free Report) last posted its earnings results on Wednesday, November 12th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.10. Ardent Health had a return on equity of 19.02% and a net margin of 3.24%.The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.55 billion. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. On average, equities analysts expect that Ardent Health will post 1.23 earnings per share for the current year.
About Ardent Health
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Further Reading
- Five stocks we like better than Ardent Health
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- SoFi Technologies: From Fintech Speculation to Profit Engine
- Energy and Oil Stocks Explained
- Gold to $5,000? What Bank of America and UBS Have to Say
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
